December 15, 2017 / 12:22 PM / a month ago

BRIEF-EU Medicines Agency Recommendations For December 2017 ‍​

Dec 15 (Reuters) - EU Medicines Agency:

* EU MEDICINES AGENCY RECOMMENDATIONS FOR DECEMBER 2017 ‍​

* EU MEDICINES AGENCY RECOMMENDS APPROVAL OF NOVO NORDISK‘S ONCE-WEEKLY DIABETES DRUG SEMAGLUTIDE‍​

* EU MEDICINES AGENCY RECOMMENDS APPROVAL OF KYOWA HAKKO KIRIN DRUG FOR GENETIC BLOOD DISORDER XLH BUROSUMAB

* EU MEDICINES AGENCY RECOMMENDS APPROVAL OF TIGENIX'S STEM CELLS TREATMENT FOR PERIANAL FISTULAS ALOFISEL Source text ID: (bit.ly/2o7BVMU) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below